These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8248234)

  • 21. Identification and characterization of a PDZ protein that interacts with activin type II receptors.
    Shoji H; Tsuchida K; Kishi H; Yamakawa N; Matsuzaki T; Liu Z; Nakamura T; Sugino H
    J Biol Chem; 2000 Feb; 275(8):5485-92. PubMed ID: 10681527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition.
    Xu J; Matsuzaki K; McKeehan K; Wang F; Kan M; McKeehan WL
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7957-61. PubMed ID: 8058741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning of zebrafish activin type IIB receptor (ActRIIB) cDNA and mRNA expression of ActRIIB in embryos and adult tissues.
    Garg RR; Bally-Cuif L; Lee SE; Gong Z; Ni X; Hew CL; Peng C
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):169-81. PubMed ID: 10459865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and characterization of goldfish activin type IIB receptor.
    Ge W; Tanaka M; Yoshikuni M; Eto Y; Nagahama Y
    J Mol Endocrinol; 1997 Aug; 19(1):47-57. PubMed ID: 9278860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vascular endothelial cell growth by activin-A.
    McCarthy SA; Bicknell R
    J Biol Chem; 1993 Nov; 268(31):23066-71. PubMed ID: 8226823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.
    Franzén P; ten Dijke P; Ichijo H; Yamashita H; Schulz P; Heldin CH; Miyazono K
    Cell; 1993 Nov; 75(4):681-92. PubMed ID: 8242743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of rat transforming growth factor-beta type II receptor.
    Tsuchida K; Lewis KA; Mathews LS; Vale WW
    Biochem Biophys Res Commun; 1993 Mar; 191(3):790-5. PubMed ID: 8385453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.
    Dewulf N; Verschueren K; Lonnoy O; Morén A; Grimsby S; Vande Spiegle K; Miyazono K; Huylebroeck D; Ten Dijke P
    Endocrinology; 1995 Jun; 136(6):2652-63. PubMed ID: 7750489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
    Greenwald J; Fischer WH; Vale WW; Choe S
    Nat Struct Biol; 1999 Jan; 6(1):18-22. PubMed ID: 9886286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes.
    Wu TC; Jih MH; Wang L; Wan YJ
    Mol Reprod Dev; 1994 May; 38(1):9-15. PubMed ID: 8049070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    Matsuzaki K; Xu J; Wang F; McKeehan WL; Krummen L; Kan M
    J Biol Chem; 1993 Jun; 268(17):12719-23. PubMed ID: 8389764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
    D'Abronzo FH; Swearingen B; Klibanski A; Alexander JM
    J Clin Endocrinol Metab; 1999 May; 84(5):1716-21. PubMed ID: 10323406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning and sequencing of a rat type II activin receptor.
    Shinozaki H; Ito I; Hasegawa Y; Nakamura K; Igarashi S; Nakamura M; Miyamoto K; Eto Y; Ibuki Y; Minegishi T
    FEBS Lett; 1992 Nov; 312(1):53-6. PubMed ID: 1385212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cloning and binding properties of the human type II activin receptor.
    Donaldson CJ; Mathews LS; Vale WW
    Biochem Biophys Res Commun; 1992 Apr; 184(1):310-6. PubMed ID: 1314589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels.
    Panchenko MP; Williams MC; Brody JS; Yu Q
    Am J Physiol; 1996 Apr; 270(4 Pt 1):L547-58. PubMed ID: 8928814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinase-inactive splice variants of the activin type I receptor.
    McKeehan K; McKeehan WI; Xu J; Liao L
    In Vitro Cell Dev Biol Anim; 1996 Mar; 32(3):131-4. PubMed ID: 8925134
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification and developmental expression of two activin receptors in baboon lung.
    Zhao Y; Silbajoris R; Young SL
    Biochem Biophys Res Commun; 1996 Dec; 229(1):50-7. PubMed ID: 8954082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.
    Muramatsu M; Yan J; Eto K; Tomoda T; Yamada R; Arai K
    Mol Biol Cell; 1997 Mar; 8(3):469-80. PubMed ID: 9188099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bovine activin receptor type IIB messenger ribonucleic acid displays alternative splicing involving a sequence homologous to Src-homology 3 domain binding sites.
    Ethier JF; Lussier JG; Silversides DW
    Endocrinology; 1997 Jun; 138(6):2425-34. PubMed ID: 9165032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.
    Moustakas A; Takumi T; Lin HY; Lodish HF
    J Biol Chem; 1995 Jan; 270(2):765-9. PubMed ID: 7822308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.